Practitioner 2010; 254 (1725):28-32

Tackling depression in patients with chronic conditions

15 Jan 2010

AUTHORS

Dr Phillip Bland BA BM BCh MRCGP DRCOG
GP with an interest in mental health, Dalton-in-Furness

Article

Compared with the general population, patients with a chronic physical health problem are two to three times more likely to be depressed.1

Moreover, for those with depression the prognosis is thought to be substantially worse: their depression is less likely to be recognised, they are less likely to accept and tolerate antidepressant treatment, and the impact of their physical illness is enduring.

Comorbid depression is associated with increased pain, greater functional impairment and reduced quality of life. Depressed patients may lack the confidence to self-manage their condition, increasing the risk of long-term complications.2 Most studies report an association between depression and all-cause mortality, and there is an even stronger link with cardiac mortality.3

In October 2009, NICE issued separate guidance for depressed adults with a chronic physical health problem for the first time.1 This should not be taken to imply that depression in these patients constitutes a distinct clinical entity, but is rather a recognition that we should consider their depression within the context of their chronic illness and disability. The main conditions covered by the guidance are listed in box 1, below.

Identification

GPs are much less likely to recognise depression when patients have a chronic condition: in one study the detection rate was only 23% compared with 94% for those with depression alone.4 This may be due to patients presenting indirectly with a worsening of their physical illness, misattribution of somatic symptoms to that condition, or time pressures within the consultation.5 In an attempt to improve the recognition of depression, previous NICE guidance had recommended the use of screening questions in high-risk groups, including patients with significant physical illnesses causing disability.

NICE acknowledges, however, that there are a number of arguments against routine screening:

  • The positive predictive value for the Whooley two question screen (see box 2, below) is low (0.11 in diabetes patients)
  • The number needed to screen is high (46 in a recent study of high-risk patients6)
  • Patients identified by screening are often reluctant to accept treatment
  • Screening only improves outcomes when linked to care management programmes7

The new guidance therefore recommends a shift of emphasis from screening to identification. We should be alert to the possibility of depression in high-risk patients and consider using the two question screen. When used in this way, its main value is in ruling out depression: the negative predictive value is very high.

NICE recommends that we should consider asking the Whooley questions when patients with a chronic condition have associated functional impairment or a past history of depression. I would also suggest their use where there is evidence that patients are struggling to adjust to their illness. The following features are all predictors of maladjustment,2 which is likely to be associated with depression:

  • physical inactivity
  • emotional repression
  • poor self-management
  • a focus on negative, rather then positive, outcomes of the illness

Classifying depression

In a change from its previous guidelines, NICE has decided to use DSM-IV (see table 1, below), rather than ICD-10, diagnostic criteria. The advantages are:

  • Most trials of treatments for depression use DSM-IV
  • DSM-IV sets a higher threshold for diagnosis, which roughly corresponds to the point above which antidepressants become more effective than placebo.

The redefined severity ranges are:

  • Subthreshold symptoms

(2-4 symptoms of depression;

function maintained)

  • Mild depression (few, if any symptoms in excess of the five required to make the diagnosis; mild functional impairment)
  • Moderate depression (symptoms or functional impairment between mild and severe)
  • Severe depression (most symptoms + marked functional impairment)

The original category of mild depression is now subsumed within the category of subthreshold symptoms, and many of those previously categorised as moderate will now be considered to have mild depression.

Even so, the current DSM-IV definition of depression can lead to overdiagnosis in patients with a chronic condition, if somatic symptoms are caused by the physical illness itself, rather than depression.

One proposed solution is to simplify the diagnostic criteria by restricting these to the five psychological symptoms (depressed mood, lack of interest, worthlessness, poor concentration and thoughts of death). Three symptoms would then be needed for a diagnosis.8 NICE recommends that we should focus on the psychological symptoms when arriving at a diagnosis of depression in patients with a chronic condition. Cognitive changes, duration and illness trajectory should also be taken into account.

NICE acknowledges the complexity of diagnosing depression and the impossibility of setting precise boundaries. It cautions against thinking that we can categorise patients with certainty and concluding that a particular severity rating should automatically imply a specific treatment. Severity rating scores such as the PHQ-9 can be particularly misleading in patients with a chronic condition, as they do not discriminate between somatic symptoms caused by the illness and those caused by depression.

Management

For patients with persistent subthreshold symptoms, mild to moderate depression or subthreshold symptoms that complicate management of the chronic condition, NICE recommends offering one of the following options:

  • structured group physical activity programme
  • group-based peer support (self-help) programme
  • individual guided self-help based on the principles of CBT (bibliotherapy)
  • computerised CBT (CCBT)

Antidepressants should only be considered if these prove ineffective, or for those with:

  • a previous history of moderate or severe depression
  • mild depression complicating the care of the chronic condition
  • subthreshold symptoms which have been present for at least two years (dysthymia)

For those patients who do not respond to a low-intensity psychosocial intervention, a high-intensity psychological intervention should be considered as an alternative to antidepressant treatment.

Exercise therapy will also improve functional ability and facilitate adjustment. It is a particularly attractive option in depressed CHD patients where inactivity is the principal mediator of the increased cardiovascular risk,9 and where neither antidepressants nor CBT have been shown to reduce the event rate.10

Peer support groups encourage ventilation of feelings and sharing of experiences,11 which is an important component of psychological adjustment to chronic disease.2 However, for all of the low-intensity psychological therapies, the evidence of efficacy in patients with a chronic condition is very limited (see table 2, above).

 

Moderate depression

NICE recommends one of the following high-intensity psychological interventions for patients with moderate depression (see table 3, above):

  • group-based CBT
  • individual CBT (if group-based CBT is declined, not appropriate or unavailable)
  • behavioural couples therapy (where the relationship may contribute to the development or maintenance of depression)

Group-based CBT is preferred on cost grounds. Combination therapy with antidepressants is not recommended as patients with a chronic condition may be reluctant to take further drugs for depression, and may be more vulnerable to side effects and drug interactions.

 

Severe depression

Combination treatment with individual CBT and an antidepressant (SSRI) is recommended for those patients with severe depression.

Table 4 (above) compares the NICE treatment recommendations with those from the British Association for Psychopharmacology.

The QoF indicators

Indicator 1

The main difficulty with indicator 1 (see table 5, opposite) is filtering out the large number of false positives. NICE recommends that, when patients have answered ‘yes' to either of the Whooley questions, the accuracy of the initial mental health assessment can be improved by asking:

 During the past month, have you often been bothered by:

  • feelings of worthlessness?
  • poor concentration?
  • thoughts of death?

The assessor should also consider the psychosocial impact of (and adjustment to) the chronic condition, depressogenic effects of medication and whether treatment of the physical condition is optimal.

 

Indicator 2

NICE endorses the use of a validated severity measure to inform and evaluate treatment. Of the two most commonly used measures, the PHQ-9 now maps directly onto NICE guidance and incorporates a measure of functional impairment; the HADS omits somatic symptoms and is thus less likely to overdiagnose depression. If using the PHQ-9, I suggest that the important boundary between mild and moderate should be set at 14/15 to reduce overdiagnosis and bring the severity ratings in line with the HADS.13 Where there is doubt regarding the origin of somatic symptoms, there would be some logic in using a PHQ-5.

 

Indicator 3

The rationale behind this indicator is to improve adherence to antidepressant treatment or, where medication is not prescribed, to encourage watchful waiting. Case management (see box 3, right) may help us to achieve this target and is advocated by the British Association for Psychopharmacology guidelines.12 However, NICE does not recommend the use of antidepressants as first-line treatment for the majority of depressed patients with a chronic condition, and it concludes that the evidence for case management in this context is sparse.

NICE recognises that collaborative care (see box 3, below) is a cost-effective intervention,16 but restricts this to patients with moderate to severe depression who have not responded to first-line treatment.

Referral

If these guidelines are followed, the expectation would be that most depressed patients with a chronic condition will be offered referral to the Improving Access to Psychotherapies (IAPT) programme. An IAPT service should comprise a team of therapists (40 for an average population of 250,000) employed by a PCT in order to deliver both low- and high-intensity psychological treatments in accordance with NICE guidance. Most patients will be referred into the service from primary care, but they will also be allowed to self-refer. Most therapy should be delivered close to home e.g. in GP surgeries.17 The IAPT website lists those PCTs which currently provide a service (www.iapt.nhs.uk/).

Patients should be referred to psychiatric services:

  • if there is a high suicide risk
  • if they are psychotic or have bipolar affective disorder
  • for collaborative care if they have moderate to severe depression which has not responded to initial psychological interventions, pharmacological treatment, or a combination of both

Conclusion

This guidance should help to reduce overdiagnosis and inappropriate prescribing of antidepressants and increase acceptance of treatment by depressed patients with a chronic condition. However, the evidence base for the proposed low-intensity psychological treatments is weak and it can be argued that it may have been better to concentrate limited resources on providing more effective care for patients with moderate to severe depression.

REFERENCES

1 National Institute for Health and Clinical Excellence.

CG 91. Depression in adults with a chronic physical health problem: treatment and management. NICE. London. 2009

2 de Ridder D, Geenen R, Kuijer R et al. Psychological adjustment to chronic disease. Lancet 2008; 372: 246-55

3 Seymour J, Benning TB. Depression, cardiac mortality and all-cause mortality. Adv Psych Treat 2009; 15: 107-13

4 Bridges KW, Goldberg DP. Somatic presentation of DSM III psychiatric disorders in primary care.

J Psychosom Res 1985; 29: 563-69

5 Pollock K, Grime J. Patients' perceptions of entitlement to time in general practice consultations for depression: qualitative study. BMJ 2002; 325: 687-92

6 Baas MD, Wittkampf KA, van Weert HC et al. Screening for depression in high-risk groups: prospective cohort study in general practice. Br J Psych 2009; 194: 399-403

7 Screening for depression in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151: 784-92

8 Andrews G, Slade T, Sunderlan M et al. Issues for DSM-V: simplifying DSM-IV to enhance utility: the case of major depressive disorder. Am J Psych 2007; 164: 1784-5

9 Whooley MA, de Jonge P, Vittinghoff E et al. Depressive symptoms, health behaviours, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-88

10 van Melle JP, de Jonge P, Honig A et al. Effects of antidepressant treatment following myocardial infarction. Br J Psych 2007; 190: 460-6

11 Evans RL, Connis RT. Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Pub Health Rep 1995; 110: 306-11

12 Anderson IM, Ferrier IN, Baldwin RC et al. Evidence-based guidelines for treating depressive disorders with antidepressants. A revision of the 2000 British Association for Psychopharmacology guidelines.

J Psychopharmacol 2008; 22: 343-96

13 Cameron IM, Crawford JR, Lawton K et al. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Prac 2008; 58: 32-6

14 Gensichen J, Beyer M, Muth C et al. Case management to improve major depression in primary health care: a systematic review. Psychol Med 2006; 36: 7-14

15 Gunn J, Diggens J, Hegarty K et al. A systematic review of complex system interventions designed to increase recovery from depression in primary care. BMC Health Serv Res; 6: 88-doi:10.1186/1472-6963-6-88

16 Simon GE, Katon WJ, Lin EHB et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psych 2007;64:65-7217 Department of Health. Improving access to psychological therapies: implementation plan: National guidelines for regional delivery. London. DH. 2008

17 Department of Health. Improving access to psychological therapies: implementation plan: National guidelines for regional delivery. London. DH. 2008